Trial Comparing the Safety and Efficacy of Two Different Oral VPV Doses With Placebo as Treatment for RV in Participants With COPD

Recruiting now · Phase 2 · Has a placebo group

Conditions studied: Rhinovirus Infection

In brief

Compare the safety and efficacy of two different oral vapendavir doses with placebo in order to determine the appropriate dose of vapendavir to reduce the severity and/or duration of respiratory symptoms associated with RV infections in patients with COPD.

Key facts

Study ID
NCT07610395
Run by
Altesa Biosciences, Inc.
People needed
180
Starts
2026-05-01
Expected to finish
2027-11-15
Last updated by the study team
2026-06-24

Who can join

Age: 40 and older, up to 85. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.